JIUTAI RCB
06122
CBHB
09668
CM BANK
03968
CEB BANK
06818
CZBANK
02016
HK Stock MarketDetailed Quotes
00690 UNI-BIO GROUP
- 0.055
- +0.002+3.77%
Trading Feb 18 09:31 CST
328.42MMarket Cap3.24P/E (TTM)
0.055High0.053Low1.16MVolume0.053Open0.053Pre Close63.24KTurnover0.02%Turnover Ratio4.58P/E (Static)5.97BShares0.09852wk High1.06P/B328.42MFloat Cap0.04652wk Low--Dividend TTM5.97BShs Float1.545Historical High--Dividend LFY3.77%Amplitude0.039Historical Low0.054Avg Price20000Lot Size--Div YieldTTM--Div Yield LFY
UNI-BIO GROUP Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 9.48%273.62M | 10.08%484.72M | 27.79%249.93M | 24.59%440.32M | 24.58%195.58M | 69.27%353.41M | 132.80%156.98M | -0.32%208.78M | -30.71%67.43M | 54.85%209.45M |
| Operating income | 9.48%273.62M | 10.08%484.72M | 27.79%249.93M | 24.59%440.32M | 24.58%195.58M | 69.27%353.41M | 132.80%156.98M | -0.32%208.78M | -30.71%67.43M | 54.85%209.45M |
| Cost of sales | 15.76%-43.03M | 12.84%-91.9M | -0.02%-51.08M | -38.00%-105.43M | -56.95%-51.07M | -175.98%-76.4M | -221.57%-32.54M | 0.90%-27.68M | 38.59%-10.12M | -58.19%-27.93M |
| Operating expenses | 15.76%-43.03M | 12.84%-91.9M | -0.02%-51.08M | -38.00%-105.43M | -56.95%-51.07M | -175.98%-76.4M | -221.57%-32.54M | 0.90%-27.68M | 38.59%-10.12M | -58.19%-27.93M |
| Gross profit | 15.96%230.59M | 17.30%392.82M | 37.61%198.85M | 20.89%334.88M | 16.12%144.51M | 52.96%277.01M | 117.13%124.44M | -0.23%181.09M | -29.10%57.31M | 54.35%181.52M |
| Selling expenses | 7.29%-117.05M | -14.20%-241.28M | -48.55%-126.25M | -13.79%-211.27M | -11.67%-84.99M | -27.60%-185.67M | -78.86%-76.11M | 2.56%-145.52M | 41.63%-42.55M | -28.75%-149.34M |
| Administrative expenses | -0.94%-23.71M | -0.72%-47.38M | 0.96%-23.49M | 0.30%-47.04M | -6.38%-23.71M | -31.67%-47.18M | -13.89%-22.29M | 39.67%-35.83M | 35.22%-19.57M | 20.60%-59.39M |
| Research and development expenses | -77.94%-20.89M | 0.57%-35.58M | 51.72%-11.74M | 28.75%-35.78M | -13.80%-24.32M | -23.30%-50.22M | -164.62%-21.37M | 4.62%-40.73M | 36.03%-8.08M | 3.33%-42.7M |
| Profit from asset sales | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --18.78M |
| Impairment and provision | ---- | ---- | ---- | 85.22%-2.31M | ---2.39M | ---15.61M | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---- | ---- | 85.22%-2.31M | ---2.39M | ---15.61M | ---- | ---- | ---- | ---- |
| Special items of operating profit | -55.57%2.86M | 56.36%8.09M | 1.23%6.44M | 142.44%5.18M | 519.72%6.36M | 229.87%2.14M | -172.12%-1.52M | -115.51%-1.64M | -96.62%2.1M | 475.26%10.6M |
| Operating profit | 63.86%71.81M | 75.62%76.68M | 183.51%43.82M | 323.51%43.66M | 388.68%15.46M | 54.17%-19.54M | 129.34%3.16M | -5.14%-42.62M | -123.45%-10.78M | 70.66%-40.54M |
| Financing cost | 37.94%-265K | -108.24%-783K | -154.17%-427K | 21.17%-376K | 38.46%-168K | -553.42%-477K | -0.74%-273K | 90.25%-73K | 54.45%-271K | -203.24%-749K |
| Special items of earning before tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -160.84%-28.25M | ---- | --46.43M |
| Earning before tax | 64.86%71.54M | 75.34%75.9M | 183.83%43.4M | 316.31%43.29M | 429.03%15.29M | 71.79%-20.01M | 126.15%2.89M | -1,480.18%-70.94M | -124.35%-11.05M | 103.71%5.14M |
| Tax | -4.18%-4.16M | -5.21%-5.02M | -514.46%-3.99M | -1,234.20%-4.78M | 33.20%-650K | 211.38%421K | -140.25%-973K | 85.90%-378K | 17.68%-405K | -1,900.75%-2.68M |
| After-tax profit from continuing operations | 71.02%67.38M | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M |
| Earning after tax | 71.02%67.38M | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M |
| Profit attributable to shareholders | 71.02%67.38M | 84.04%70.88M | 169.15%39.4M | 296.58%38.51M | 663.64%14.64M | 72.53%-19.59M | 116.73%1.92M | -3,000.33%-71.32M | -125.52%-11.46M | 101.77%2.46M |
| Basic earnings per share | 75.81%0.0109 | 81.97%0.0111 | 169.57%0.0062 | 296.77%0.0061 | 666.67%0.0023 | 72.07%-0.0031 | 116.67%0.0003 | -2,875.00%-0.0111 | -124.66%-0.0018 | 101.79%0.0004 |
| Diluted earnings per share | 75.81%0.0109 | 81.97%0.0111 | 169.57%0.0062 | 296.77%0.0061 | 666.67%0.0023 | 72.07%-0.0031 | 116.67%0.0003 | -2,875.00%-0.0111 | -124.66%-0.0018 | 0.0004 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.